This parasitic disease, known as the tsetse fly, permanently threatens 60 million people in Africa. This new treatment could eliminate the transmission of sleeping sickness by 2030.
A drug, acoziborole, developed by Sanofi and a research organization founded by the World Health Organization (WHO), can cure sleeping sickness, reveals the medical journal The Lancet. This parasitic disease, known as the tsetse fly, permanently threatens 60 million people in Africa.
There are treatments for human African trypanosomiasis, otherwise known as sleeping sickness, but they usually require hospitalization. This parasite invades the nervous system, causing in particular sleep disorders, before causing death.
Several tablets of this new drug, acoziborole, swallowed at once can cure. It is 95% effective a year and a half after taking the treatment, according to The Lancet. This drug eliminates the parasite in humans. It could eliminate the transmission of sleeping sickness by 2030.
woodworkers.com, alpilean.com, exipure.com, amazonian.com, prodentim.com, ikariajuice.com, fluxactIve.com, glucotrust.com, soulmate.com
Ukraine Resilient at a Crucial Crossroads In the heart of Eastern Ukraine, the city of…
Italy to Build Bridge to Sicily: A Dream Project or a Nightmare? For decades, the…
Construction of Deep Sea Port in Świnoujście Approved to Continue The deep sea port in…
EU Takes Action Against Plastic Pollution A new round of negotiations for a global plastic…
Electric Aircraft Milestone: A Leap Forward in Sustainable Aviation Technology The Netherlands recently made history…
French Elections: The Rise of Marine Le Pen and Jordan Bardella The recent French elections…
